Importantly, since both insulin-expressing populations were present in both the primary tumour and the metastasis, any novel therapeutic strategy in canine insulinoma would need to be effective at targeting both types of insulin-expressing cells. This evidence concerns the gene INS and pancreatic insulinoma.